Cargando…
Physician Perspectives on Reducing Curative Cancer Treatment Intensity for Populations Underrepresented in Clinical Trials
BACKGROUND: Historically, clinical trials involved adding novel agents to standard of care to improve survival. There has been a shift to an individualized approach with testing less intense treatment, particularly in breast cancer where risk of recurrence is low. Little is known about physician per...
Autores principales: | Rocque, Gabrielle B, Andrews, Courtney, Lawhon, Valerie M, Ingram, Stacey A, Frazier, Rachel M, Smith, Mary Lou, Wagner, Lynne I, Zubkoff, Lisa, Wallner, Lauren P, Wolff, Antonio C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732232/ https://www.ncbi.nlm.nih.gov/pubmed/36215065 http://dx.doi.org/10.1093/oncolo/oyac191 |
Ejemplares similares
-
Facilitators and barriers to reducing chemotherapy for early-stage breast cancer: a qualitative analysis of interviews with patients and patient advocates
por: Andrews, Courtney, et al.
Publicado: (2022) -
Unprofessional peer reviews disproportionately harm underrepresented groups in STEM
por: Silbiger, Nyssa J., et al.
Publicado: (2019) -
Women are underrepresented on the editorial boards of journals in environmental biology and natural resource management
por: Cho, Alyssa H., et al.
Publicado: (2014) -
Medical Management of Terminal Illness: A Statement of the Committee on Ethical Issues in Medicine of the Royal College of Physicians
por: Black, Douglas
Publicado: (1993) -
Research Based on Archived Information and Samples: Recommendations from the Committee on Ethical Issues in Medicine of the Royal College of Physicians
Publicado: (1999)